Visual analysis of clinical comprehensive evaluation of drugs in China by bibliometric analysis
10.12206/j.issn.2097-2024.202301026
- VernacularTitle:基于文献计量学的国内临床综合评价研究的可视化分析
- Author:
Juan LI
1
,
2
;
Tao PANG
2
;
Deduo XU
2
;
Erli MA
3
;
Weidong CHEN
4
;
Feng ZHANG
2
;
Binglong LIU
3
Author Information
1. Anhui University of Chinese Medicine, Hefei 230012, China
2. Department of Pharmacy, Changzheng Hospital, Navy Medical University, Shanghai 200003， China.
3. Shanghai Pharmaceutical Association, Shanghai 200040, China.
4. Anhui University of Chinese Medicine, Hefei 230012, China.
- Keywords:
Clinical comprehensive evaluation;
Bibliometric;
CiteSpace;
Information visualization
- From:
Journal of Pharmaceutical Practice
2023;41(8):509-514
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the research status and predict the development trend of clinical comprehensive evaluation of drugs in China, and to provide reference for clinical comprehensive evaluation. Methods CNKI, Wanfang and VIP database were used to search the published articles of clinical comprehensive evaluation. Literature searching was set from the building time of the database to 2022, the basic information about the published articles was obtained for the evaluation of the literature quality. Bibliometrics and CiteSpace 6.1.R3 software were used to visualize the research authors, research institutions, and key words. Results After data screening, a total of 126 Chinese published articles were selected. The analysis showed that the numbers of published articles were rising continuously, and China Academy of Chinese Medical Sciences and Xie Yanming were the institute and the author with the maximum number of literatures, respectively. Conclusion The clinical comprehensive evaluation of drugs was conducted based on the clinical value of drugs, guided by the policy requirements. It is suggested that researchers should conduct the comprehensive evaluation according to the focus and requirements of government agencies, the pharmaceutical industry and the clinical applications.
